GlobeNewswire

Progress and Potential for Achieving Cleaner Air on a Global Basis

Dela

Adoption of New Generation Diesel Technology Delivers Rapid Clean Air Benefits 

New understanding of global air quality highlights the need for technologies like new-generation diesel engines, which are capable of accelerating emissions reductions

WASHINGTON, April 19, 2018 (GLOBE NEWSWIRE) -- Recent reports highlighting air quality conditions in the United States (State of the Air) and globally (State of Global Air 2018) celebrate the progress made in developed and developing countries, but also emphasize significant disparities in progress toward reducing levels of key pollutants such as particulate matter and ozone.

"Achieving continued clean air progress while also sustaining economic growth is possible. Cities and countries must move to proven cleaner engines and fuels," said Allen Schaeffer, executive director of the Diesel Technology Forum. "We can and should bring the tremendous benefits of new technology diesel engines to communities and countries large and small around the world so they too can reduce emissions while efficiently building their economies and infrastructure, improving the quality of life for people everywhere."

"While it is surprising the extent that particulate matter from household cooking and non-transportation sources contributes to the health burden in the new report, the opportunities for reducing fine particle emissions from the motor vehicle and industrial engine segments are also part of the solution," said Schaeffer. "Worldwide harmonization of fuel quality and vehicle engine emissions standards would leverage the societal benefits of new diesel technology to more users around the world."

For example: Today, nearly one in every two trucks on the road in the United States are equipped with fine particle- and smog-reducing advanced clean diesel technology. In the most comprehensive study conducted on these engines, The Health Effects Institute found "substantial emissions and health benefits from US 2007/2010 and Euro VI/6 engines," demonstrating "dramatic improvements in emissions and the absence of any significant health effects."

In 2000, the U.S. Environmental Protection Agency (EPA) challenged diesel engine and truck manufacturers to achieve near-zero emissions in their products by 2010, with diesel off-road equipment manufacturers targeting 2014. Following a switch to ultra-low-sulfur diesel fuel in 2006, today's industry has not only met the near-zero challenge, but is well into the second and third generations of new diesel technologies. The industry continues to build on this success by seeking lower greenhouse gas emissions and greater fuel efficiency for the diesel engine.

The societal benefits of these efforts are now clear: According to the American Lung Association's analysis, ".the best progress [in 2018] came in the continued reduction of year-round particle pollution, thanks to cleaner power plants and increased use of cleaner vehicles and engines."

"Clean diesel technology plays an increasing role in helping cities, states and countries achieve cleaner air quality worldwide," said Schaeffer. "The latest generation diesel engines - ones that use selective catalytic reduction systems and diesel particulate filters - offer near-zero particulate matter (PM) and nitrogen oxides (NOx) emissions. With such technology, NOx emissions can be reduced by up to 90 percent while simultaneously reducing hydrocarbon and carbon monoxide emissions by 50-90 percent, and PM emissions by 30-50 percent. Ultra-low-sulfur diesel fuel immediately cuts soot emissions from diesel vehicles and equipment by 10 percent."

The State of Global Air 2018, compiled by The Health Effects Institute, the Institute for Health Metrics and Evaluation at the University of Washington, and the University of British Columbia, dramatically expands our understanding of all the sources that contribute to fine-particle air pollution; this was identified as the greatest environmental risk factor worldwide. Ninety-five percent of the world's population lives in areas exceeding the World Health Organization's (WHO) guideline for healthy air, and nearly 60 percent live in areas that do not meet even the WHO's least-stringent air quality target.

"Global considerations of air quality improvement must go beyond the road transport sector because diesel engines not only power the majority of commercial vehicles, but also nearly all marine and rail, industrial, agricultural and construction machines and equipment," said Schaeffer. "Similar clean diesel technologies that reduce fine particle emissions from commercial vehicles are now available in these large engine applications."

About The Diesel Technology Forum
The Diesel Technology Forum is a non-profit organization dedicated to raising awareness about the importance of diesel engines, fuel and technology. Forum members are leaders in clean diesel technology and represent the three key elements of the modern clean-diesel system: advanced engines, vehicles and equipment, cleaner diesel fuel and emissions-control systems. For more information, visit  http://www.dieselforum.org .

Connect with the Diesel Technology Forum
For the latest insights and information from the leaders in clean diesel technology, join us on Facebook, follow us on Twitter @DieselTechForum, or YouTube @DieselTechForum and connect with us on LinkedIn. Get it all by subscribing to our newsletter Diesel Direct for a weekly wrap-up of clean diesel news, policy analysis and more direct to your inbox.

Contact:
Sarah Dirndorfer
sdirndorfer@dieselforum.org
301.668.7230 (o) 301.706.8276 (c)




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Diesel Technology Forum via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum